chr11-18558329-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001040697.4(UEVLD):c.614G>A(p.Gly205Asp) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000484 in 1,445,440 control chromosomes in the GnomAD database, with no homozygous occurrence. 14/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001040697.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UEVLD | NM_001040697.4 | c.614G>A | p.Gly205Asp | missense_variant, splice_region_variant | 7/12 | ENST00000396197.8 | NP_001035787.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UEVLD | ENST00000396197.8 | c.614G>A | p.Gly205Asp | missense_variant, splice_region_variant | 7/12 | 5 | NM_001040697.4 | ENSP00000379500 | P1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.00000824 AC: 2AN: 242672Hom.: 0 AF XY: 0.0000152 AC XY: 2AN XY: 131244
GnomAD4 exome AF: 0.00000484 AC: 7AN: 1445440Hom.: 0 Cov.: 27 AF XY: 0.00000695 AC XY: 5AN XY: 718998
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 11, 2022 | The c.614G>A (p.G205D) alteration is located in exon 7 (coding exon 7) of the UEVLD gene. This alteration results from a G to A substitution at nucleotide position 614, causing the glycine (G) at amino acid position 205 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at